OOIR: Observatory of International Research

Papers

(The TQCC of Hypertension in Pregnancy is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Genome-wide association study reveals HSF2, GJA1 and TRIM36 as susceptibility genes for preeclampsia: a community-based population study in Tianjin, China	15
Inflammasomes in placental explants of women with preeclampsia cultured with monosodium urate may be modulated by vitamin D	13
Risk of gestational hypertension and preeclampsia in pregnant women with new onset blood pressure of 120–129/≤89 mmHg: a meta-analysis of prospective studies	10
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial	10
Blood pressure medication use and postpartum hospital readmission among preeclampsia patients	9
A clinical and in-silico study exploring the association of CASP-3, NF-kB, miR-187, and miR-146 in pre-eclampsia	9
Administration of corticosteroid therapy for HELLP syndrome in pregnant women: evidences from seven randomized controlled trials	9
Effects of hypertensive disorders of pregnancy on the complications in very low birth weight neonates	9
Intraabdominal pressure as a marker for physiologic and pathologic processes in pregnancy	8
Expression of Concern: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk	7
Targeting oxidative stress in preeclampsia	7
Coronavirus disease 2019 (COVID-19) and the risk of hypertensive disorders of pregnancy: a retrospective cohort study	7
Short stature in small-for-gestational-age offspring born to mothers with hypertensive disorders of pregnancy	6
First-trimester maternal renin-angiotensin-aldosterone system activation and the association with maternal telomere length after natural and IVF/ICSI conceived pregnancies: the Rotterdam periconceptio	5
Trimester and severity of SARS-CoV-2 infection during pregnancy and risk of hypertensive disorders in pregnancy	5
Association between time of delivery and composite adverse outcomes in pregnancies complicated by hypertensive disorders	5
The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis	5
Predictability of adverse outcomes in hypertensive disorders of pregnancy: a multicenter prospective cohort study	5
Association between interleukin-32 gene polymorphism and susceptibility to preeclampsia	5
Use of the USCOM® noninvasive cardiac output measurement system to predict the development of pre-eclampsia in hypertensive pregnancies	5
IL-25 promotes trophoblast proliferation and invasion via binding with IL-17RB and associated with PE	4
Causal associations of metabolic dysfunction-associated steatotic liver disease with gestational hypertension and preeclampsia: a two-sample Mendelian randomization study	4
Interleukin-1β and uric acid as potential second-trimester predictive biomarkers of preeclampsia	4
Distinguishing preeclampsia using the falling scaled slope (FSS) --- a novel photoplethysmographic morphological parameter	4
Soluble endoglin versus sFlt-1/PlGF ratio: detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohort	3

Association between hypertensive disorders of pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring: a systematic review and meta-analysis	3
Relationship between the hemodynamic profile and resistant hypertension in pregnant patients with hypertensive crisis	3
MiR-140-5p exerts a protective function in pregnancy-induced hypertension via mediating TGF-β/Smad signaling pathway	3
Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?	3
The obesity associated FTO gene polymorphism and the risk of preeclampsia in Iranian women: A case–control study	3
Soluble urinary somatic angiotensin converting enzyme is overexpressed in patients with preeclampsia: a potential new marker for the disease?	3
Magnesium sulfate improves blood flow of uterine, umbilical, and fetal middle cerebral arteries in women with severe preeclampsia at 30-34 gestational weeks	3
Maternal and neonatal outcome among women with early-onset preeclampsia and late-onset preeclampsia	3